Systematic review and meta-analysis of the current literature on tocilizumab in patients with refractory Takayasu arteritis.

Limei Kang,Yang Liu,Zhongling Luo,Yueyuan Zhou,Bo Chen,Geng Yin,Qibing Xie

Frontiers in immunology（2023）

引用 1|浏览3

暂无评分

摘要

TCZ treatment can provide favorable outcomes in terms of inflammatory markers, steroid-sparing effects, clinical response, drug retention and minimizing adverse effects for patients with refractory TAK.

查看译文

关键词

Takayasu arteritis,baseline characteristic,clinical outcome,refractory,tocilizumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要